Company · Montréal, Quebec, Canada
Baker Cummins Inc
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 25
- 0 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 11
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| AQUADERM-30 SUNSCREEN LOTION | 02230196 | Cancelled Pre Market | |
| BCI ATENOLOL | 02257629 | Cancelled Post Market | |
| BCI ATENOLOL | 02257637 | Cancelled Post Market | |
| BCI CAPTOPRIL TABLETS | 02259540 | Cancelled Pre Market | |
| BCI CAPTOPRIL TABLETS | 02259559 | Cancelled Pre Market | |
| BCI CAPTOPRIL TABLETS | 02259567 | Cancelled Pre Market | |
| BCI CAPTOPRIL TABLETS | 02259575 | Cancelled Pre Market | |
| BCI FAMOTIDINE | 02257645 | Cancelled Pre Market | |
| BCI FAMOTIDINE | 02257653 | Cancelled Pre Market | |
| BCI FLUOXETINE | 02266776 | Cancelled Pre Market | |
| BCI FLUVOXAMINE TABLETS | 02257661 | Cancelled Post Market | |
| BCI FLUVOXAMINE TABLETS | 02257688 | Cancelled Post Market | |
| BCI GABAPENTIN | 02266768 | Cancelled Pre Market | |
| BCI METFORMIN | 02265575 | Cancelled Post Market | |
| BCI METFORMIN | 02265583 | Cancelled Post Market | |
| BCI RANITIDINE | 02265591 | Cancelled Pre Market | |
| BCI RANITIDINE | 02265605 | Cancelled Pre Market | |
| BCI SALBUTAMOL INHALATION SOLUTION | 02259583 | Cancelled Post Market | |
| BCI SALBUTAMOL INHALATION SOLUTION | 02259591 | Cancelled Pre Market | |
| BCI SIMVASTATIN | 02265656 | Cancelled Pre Market | |
| BCI SIMVASTATIN | 02265664 | Cancelled Pre Market | |
| BCI SIMVASTATIN | 02265672 | Cancelled Pre Market | |
| BCI SIMVASTATIN | 02265680 | Cancelled Pre Market | |
| BCI SIMVASTATIN | 02265699 | Cancelled Pre Market | |
| TRISYN | 00781371 | Cancelled Post Market |
Notices of Compliance
Newest first.
- BCI GABAPENTINApril 13, 2005 · NOC 6425 · Abbreviated New Drug Submission (ANDS)
- BCI PRAVASTATINApril 13, 2005 · NOC 6426 · Abbreviated New Drug Submission (ANDS)
- BCI FLUOXETINEApril 8, 2005 · NOC 6395 · New Drug Submission (NDS)
- BCI SIMVASTATINMarch 2, 2005 · NOC 6296 · Abbreviated New Drug Submission (ANDS)
- BCI RANITIDINEMarch 2, 2005 · NOC 6297 · Abbreviated New Drug Submission (ANDS)
- BCI METFORMINMarch 2, 2005 · NOC 6298 · Abbreviated New Drug Submission (ANDS)
- BCI SALBUTAMOL INHALATION SOLUTIONOctober 12, 2004 · NOC 5566 · Abbreviated New Drug Submission (ANDS)
- BCI CAPTOPRIL TABLETSOctober 12, 2004 · NOC 5567 · Abbreviated New Drug Submission (ANDS)
- BCI ATENOLOLAugust 17, 2004 · NOC 4907 · Abbreviated New Drug Submission (ANDS)
- BCI FAMOTIDINEAugust 17, 2004 · NOC 4908 · Abbreviated New Drug Submission (ANDS)
- BCI FLUVOXAMINE TABLETSAugust 13, 2004 · NOC 4838 · Abbreviated New Drug Submission (ANDS)